Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative diabetic retinopathy

Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative diabetic retinopathy

US Patent 12280093 · Granted Apr 22, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and formulations for treating vascular eye diseases using aflibercept an2021
Methods and formulations for treating vascular eye diseases using aflibercept an2021
Use of a VEGF antagonist to treat angiogenic eye disorders2021
Use of a VEGF antagonist to treat angiogenic eye disorders2021
Use of a VEGF antagonist to treat angiogenic eye disorders2021
Compositions comprising IL6R antibodies for the treatment of uveitis and macular2021
Compositions comprising IL6R antibodies for the treatment of uveitis and macular2021
Systems and methods for managing insurance account documents2014
Therapeutic regimen for treating cancer comprising the administration of adenovi2007
Method for preventing metalorganic precursor penetration into porous dielectrics2007
Method to improve barrier layer adhesion2004